Prof. Mojisola Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), has announced that Nigeria will soon begin developing vaccines.
Adeyeye, who said this at the 2019 and 2020 NAFDAC Staff Recognition Award Ceremony on Friday December 18, said the upgrade of established laboratories across the nation and the achievement of ISO 9001 in June 2019, which is the most recognized quality management system (QMS) standard in the world, puts the country in good standing to aspire to reach level 3 maturity, allowing the country to manufacture
In Africa, NAFDAC is a leading national regulator. International standards and best practices are governed by the Department.
Our new norm began three years ago when we started a quality control system that now lets us focus more on the customers, the organization’s image, to make sure we are a standard organization guided by operating procedures. This has helped us to reach ISO 9001 in June 2019. We went on to global benchmarking, where international best practices have been introduced and international best practices are still being adopted.
With regard to the establishment of global benchmarking and implementation of international best practices by the World Health Organization (WHO), we want to achieve maturity level three so that Nigeria can develop its own vaccines, and we are all working on this every day.
We are upgrading the laboratories of the department to international requirements using ISO 17025 compliant equipment.
With changes in new equipment and supplies, NAFDAC laboratories are evolving very rapidly.
The re-accreditation of our four laboratories that were accredited before I came. We have also been certified for the first time by the Yaba Biologies and Vaccines Lab, a modern facility. And very soon, our two other laboratories will be certified.
The agency has renewed and modified its 5 + 5 validity strategy because we want local content in similar efforts to increase the local development of pharmaceuticals in Nigeria. We want more local demand, from 70% of imports to 70% of locally produced goods, to reverse it.
We create traceability because, to say the least, our supply chain is chaotic. We have already implemented track and trace traceability that will ensure that what the patient is taking is the goods that depart the manufacturer’s site.
This is a technology-driven project, and NAFDAC is the second country to implement this initiative in Africa. When they come, we use it for covid-19 vaccines.
NAFDAC leads the continent in ensuring that covid-19 vaccines can be tracked and traced to patients and that long-term adverse effects can be monitored as well. This is our new standard and that is because we are changing our way of thinking and we want to protect our people’s health.
On the finances of the organization, added Adeyeye;
We developed the Cost Budgeting Directorate because financial health is part of the quality management system. I inherited a debt of N3.2 billion.
NAFDAC is solvent now because by paying the debt of N3.01 billion in one year we have excluded NAFDAC from insolvency. We have learned lessons, and we are always learning lessons about how not to be wasteful on a rainy day, and how to protect it.